Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
TerSera Therapeutics LLC
TerSera Therapeutics LLC (TerSera) will consider, on a case-by-case basis, requests by treating physicians to file a single patient investigational new drug application for expanded access to margetuximab and for TerSera to supply margetuximab for single patient use.
Age
Any age
Sex
Any
Healthy volunteers
Not accepted
You may be eligible if
TerSera may consider requests on a case-by-case basis from treating physicians for patients not otherwise eligible for margetuximab clinical studies.
Treating physicians should consider approved therapies for a patient's disease, as well as ongoing clinical studies, before seeking expanded access use with an investigational agent.
Clareo Health | Margetuximab Expanded Access Program
